Characterisation of Dengue Vaccine (Qdenga®, TAK-003)-induced Humoral and Cellular Specific Immunity in Vaccinees with and Without Prior Exposure to Flavivirus Infections or Vaccination
Latest Information Update: 21 Jan 2025
Price :
$35 *
At a glance
- Drugs Dengue tetravalent vaccine Takeda (Primary)
- Indications Dengue
- Focus Pharmacodynamics
- 21 Jan 2025 New trial record